JAT’s agreement with Woolworths well received
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Consumer goods supplier, Jat Energy (ASX:JAT), has penetrated another major end market, announcing that Woolworths (ASX:WOW) has confirmed that it will offer NEURIO Formulated Milk Powder with Lactoferrin for sale to Chinese consumers via its flagship store on cross-border platform TMall Global from early August 2018.
The Neurio range will be sold to Chinese consumers on JD Global’s cross border and supermarket platforms: www.JD.com and www.JD.hk.
JD placed orders for Neurio – Lactoferrin milk powder and Neurio – DHA Algae oil softgel.
The news flow from JAT has been outstanding with the company only announcing last week that it had kicked off a high visibility campaign to launch NEURIO products on Alibaba backed Xiaohongshu, a social media e-commerce shopping app based in Shanghai which targets 18 to 35-year-old women.
This highlights the substantial benefits of JAT’s Chinese inspection and quarantining import licences, as well as the company’s distribution channels, including its online and off-line resources that are required to launch and grow Australian brands and products in the Chinese market.
However it is an early stage of this company’s development and if considering this stock for your portfolio you should take all public information into account and seek professional financial advice.
The following are just some of the brands that JAT provides services to.
The Woolworths deal is important as Woolworths’ TMall Global online store (woolworths.tmall.hk) is the only online store for Chinese consumers to purchase products direct from Woolworths.
Consequently, it wasn’t surprising to see the company’s shares soar more than 10 per cent to hit 10 cents in morning trading under higher than average volumes.
The past performance of this product is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.
Product display and artwork design is currently underway and management expects NEURIO Formulated Milk Powder with Lactoferrin to be available from sale on the platform in early August.
Executive director Wilton Yao said, “It represents a strong signal about the popularity of NEURIO Lactoferrin in the Chinese market and adds to the critical mass of brand exposure needed to drive sales. The board is very confident about the future for Neurio products.”
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.